J. A. Portero

581 total citations
11 papers, 444 citations indexed

About

J. A. Portero is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, J. A. Portero has authored 11 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 4 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in J. A. Portero's work include Multiple Myeloma Research and Treatments (7 papers), Acute Myeloid Leukemia Research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). J. A. Portero is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Acute Myeloid Leukemia Research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). J. A. Portero collaborates with scholars based in Spain. J. A. Portero's co-authors include Jesús F. San Miguel, Jesús María Hernández‐Rivas, F. Casanova, Rafael Jiménez, Abelardo Bárez, Fernando Ortega, Ramón García‐Sánz, Marcos González, M. Angeles Carnero and D Borrego and has published in prestigious journals such as International Journal of Cancer, British Journal of Haematology and American Journal of Hematology.

In The Last Decade

J. A. Portero

11 papers receiving 439 citations

Peers

Countries citing papers authored by J. A. Portero

Since Specialization

Citations

This map shows the geographic impact of J. A. Portero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. A. Portero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. A. Portero more than expected).

Fields of papers citing papers by J. A. Portero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. A. Portero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. A. Portero. The network helps show where J. A. Portero may publish in the future.

Co-authorship network of co-authors of J. A. Portero

This figure shows the co-authorship network connecting the top 25 collaborators of J. A. Portero. A scholar is included among the top collaborators of J. A. Portero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. A. Portero. J. A. Portero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Bone remodelation markers are useful in the management of monoclonal gammopathies 2004 ·The Hematology Journal ·José M. Hernández, (unknown), José Antonio Queizán, Rosa Fisac, (unknown), (unknown), Ramón García‐Sánz, (unknown), Abelardo Bárez, María José Calmuntia, Javier García‐Frade, J. A. Portero, (unknown), Carmen Aguilera, J.A. Navajo, Jesús F. San Miguel	12
2	Proliferative activity of plasma cells is the most relevant prognostic factor in elderly multiple myeloma patients 2004 ·International Journal of Cancer ·Ramón García‐Sánz, (unknown), (unknown), Jesús María Hernández‐Rivas, M C López-Berges, Natalia de las Heras, Javier Fernández‐Calvo, Fernando Ortega, J. A. Portero, Abelardo Bárez, Josefina Galende, Alberto Órfão, Jesús F. San Miguel	36
3	Immunophenotypic analysis of Waldenstrom's macroglobulinemia 2003 ·Seminars in Oncology ·Jesús F. San Miguel, María‐Belén Vídriales, Enrique M. Ocio, Gema Mateo, Fermín Sánchez‐Guijo, María Luz Sánchez, L. Escribano, Abelardo Bárez, Manuel Moro, Jesús María Hernández‐Rivas, Carmen Aguilera, Rebeca Cuello, Javier García‐Frade, Rafael López Castro, J. A. Portero, (unknown)	127
4	[High cardiac output in myeloma patients. Its prevalence and clinical characteristics. The Castile-León Cooperative Group for the Study of Monoclonal Gammapathies]. 1997 ·PubMed ·(unknown), J. A. Portero, D Borrego, Abelardo Bárez, Jesús F. San Miguel	2
5	Detection of trisomy 8 using conventional cytogenetic techniques and interphase FISH analysis in 34 myeloid disorders: A comparative study 1997 ·Cancer Genetics and Cytogenetics ·Eva Arranz, Mercedes Robledo, Beatriz Fernández-Martínez, Elena Prieto, J. A. Portero, Javier Benı́tez	3
6	Analysis of natural killer‐associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications 1996 ·British Journal of Haematology ·Ramón García‐Sánz, Marcos González, Alberto Órfão, (unknown), Jesús María Hernández‐Rivas, D Borrego, M. Angeles Carnero, F. Casanova, Abelardo Bárez, Rafael Jiménez, J. A. Portero, Jesús F. San Miguel	64
7	Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients 1995 ·British Journal of Haematology ·Ramón García‐Sánz, (unknown), Marcos González, (unknown), Jesús María Hernández‐Rivas, Fernando Ortega, D Borrego, M. Angeles Carnero, F. Casanova, Rafael Jiménez, J. A. Portero, Jesús F. San Miguel	62
8	Increased expression of natural‐killer‐associated and activation antigens in multiple myeloma 1992 ·American Journal of Hematology ·(unknown), Jesús F. San Miguel, (unknown), Manuel Moro, Jesús María Hernández‐Rivas, Fernando Ortega, Rafael Jiménez, (unknown), Marta R. Romero, F. Casanova, M. A. Sanz, J. A. Portero, (unknown)	41
9	[Prognostic effect of beta 2-microglobulin in multiple myeloma]. 1992 ·PubMed ·Fernando Ortega, Marta Sonia González, Marı́a Jesús Moro, (unknown), (unknown), Michael G. Martin, Jesús María Hernández‐Rivas, (unknown), J. A. Portero, Miguel Á. Sanz	6
10	Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease 1991 ·British Journal of Haematology ·Jesús F. San Miguel, (unknown), (unknown), (unknown), (unknown), Fernando Ortega, Rafael Jiménez, (unknown), Marta R. Romero, F. Casanova, Miguel Á. Sanz, (unknown), J. A. Portero, (unknown)	79
11	TdT activity in acute myeloid leukemias defined by monoclonal antibodies 1986 ·American Journal of Hematology ·Jesús F. San Miguel, Marcos González, M.C. del Cañizo, (unknown), J. A. Portero, (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact